{
  "DOI": "10.1007/s10689-016-9956-7",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-016-9956-7",
  "alternative-id": [
    "9956"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Yadav",
      "given": "Siddhartha",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Reeves",
      "given": "Ashley",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Campian",
      "given": "Sarah",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Paine",
      "given": "Amy",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zakalik",
      "given": "Dana",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2016,
        11,
        22
      ]
    ],
    "date-time": "2016-11-22T12:34:05Z",
    "timestamp": 1479818045000
  },
  "deposited": {
    "date-parts": [
      [
        2017,
        6,
        22
      ]
    ],
    "date-time": "2017-06-22T10:59:34Z",
    "timestamp": 1498129174000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        6
      ]
    ],
    "date-time": "2024-03-06T11:16:26Z",
    "timestamp": 1709723786652
  },
  "is-referenced-by-count": 14,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2016,
        11,
        22
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2017,
          7
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "unspecified",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2016,
            11,
            22
          ]
        ],
        "date-time": "2016-11-22T00:00:00Z",
        "timestamp": 1479772800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-016-9956-7/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-016-9956-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-016-9956-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "319-328",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2016,
        11,
        22
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2016,
        11,
        22
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2017,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/S1470-2045(11)70076-6",
      "author": "B Zhang",
      "doi-asserted-by": "crossref",
      "first-page": "477",
      "issue": "5",
      "journal-title": "Lancet Oncol",
      "key": "9956_CR1",
      "unstructured": "Zhang B, Beeghly-Fadiel A, Long J, Zheng W (2011) Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol 12(5):477–488",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.tig.2007.12.007",
      "author": "ER Mardis",
      "doi-asserted-by": "crossref",
      "first-page": "133",
      "issue": "3",
      "journal-title": "Trends Genet",
      "key": "9956_CR2",
      "unstructured": "Mardis ER (2008) The impact of next-generation sequencing technology on genetics. Trends Genet 24(3):133–141",
      "volume": "24",
      "year": "2008"
    },
    {
      "author": "C Meldrum",
      "first-page": "177",
      "issue": "4",
      "journal-title": "Clin Biochem Rev",
      "key": "9956_CR3",
      "unstructured": "Meldrum C, Doyle MA, Tothill RW (2011) Next-generation sequencing for cancer diagnostics: a practical perspective. Clin Biochem Rev 32(4):177–195",
      "volume": "32",
      "year": "2011"
    },
    {
      "DOI": "10.1200/JCO.2013.53.6607",
      "author": "AW Kurian",
      "doi-asserted-by": "crossref",
      "first-page": "2001",
      "issue": "19",
      "journal-title": "J Clin Oncol",
      "key": "9956_CR4",
      "unstructured": "Kurian AW, Hare EE, Mills MA, Kingham KE, McPherson L, Whittemore AS, McGuire V, Ladabaum U, Kobayashi Y, Lincoln SE, Cargill M, Ford JM (2014) Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol 32(19):2001–2009",
      "volume": "32",
      "year": "2014"
    },
    {
      "DOI": "10.1038/gim.2014.40",
      "author": "H LaDuca",
      "doi-asserted-by": "crossref",
      "first-page": "830",
      "issue": "11",
      "journal-title": "Genet Med",
      "key": "9956_CR5",
      "unstructured": "LaDuca H, Stuenkel AJ, Dolinsky JS, Keiles S, Tandy S, Pesaran T, Chen E, Gau CL, Palmaer E, Shoaepour K, Shah D, Speare V, Gandomi S, Chao E (2014) Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients. Genet Med 16(11):830–837",
      "volume": "16",
      "year": "2014"
    },
    {
      "DOI": "10.1002/cncr.29010",
      "author": "N Tung",
      "doi-asserted-by": "crossref",
      "first-page": "25",
      "issue": "1",
      "journal-title": "Cancer",
      "key": "9956_CR6",
      "unstructured": "Tung N, Battelli C, Allen B, Kaldate R, Bhatnagar S, Bowles K, Timms K, Garber JE, Herold C, Ellisen L, Krejdovsky J, DeLeonardis K, Sedgwick K, Soltis K, Roa B, Wenstrup RJ, Hartman AR (2015) Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer 121(1):25–33",
      "volume": "121",
      "year": "2015"
    },
    {
      "DOI": "10.1200/JCO.2014.56.0474",
      "author": "M Robson",
      "doi-asserted-by": "crossref",
      "first-page": "1987",
      "issue": "19",
      "journal-title": "J Clin Oncol",
      "key": "9956_CR7",
      "unstructured": "Robson M (2014) Multigene panel testing: planning the next generation of research studies in clinical cancer genetics. J Clin Oncol 32(19):1987–1989",
      "volume": "32",
      "year": "2014"
    },
    {
      "DOI": "10.1200/JCO.2015.63.0996",
      "author": "ME Robson",
      "doi-asserted-by": "crossref",
      "first-page": "3660",
      "issue": "31",
      "journal-title": "J Clin Oncol",
      "key": "9956_CR8",
      "unstructured": "Robson ME, Bradbury AR, Arun B, Domchek SM, Ford JM, Hampel HL, Lipkin SM, Syngal S, Wollins DS, Lindor NM (2015) American society of clinical oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 33(31):3660–3667",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.6004/jnccn.2014.0128",
      "author": "MJ Hall",
      "doi-asserted-by": "crossref",
      "first-page": "1339",
      "issue": "9",
      "journal-title": "J Natl Compr Canc Netw",
      "key": "9956_CR9",
      "unstructured": "Hall MJ, Forman AD, Pilarski R, Wiesner G, Giri VN (2014) Gene panel testing for inherited cancer risk. J Natl Compr Canc Netw 12(9):1339–1346",
      "volume": "12",
      "year": "2014"
    },
    {
      "DOI": "10.1001/jamaoncol.2015.2699",
      "author": "EM Swisher",
      "doi-asserted-by": "crossref",
      "first-page": "951",
      "issue": "7",
      "journal-title": "JAMA Oncol",
      "key": "9956_CR10",
      "unstructured": "Swisher EM (2015) Usefulness of multigene testing: catching the train that’s left the station. JAMA Oncol 1(7):951–952",
      "volume": "1",
      "year": "2015"
    },
    {
      "DOI": "10.1001/jamaoncol.2015.2690",
      "author": "A Desmond",
      "doi-asserted-by": "crossref",
      "first-page": "943",
      "issue": "7",
      "journal-title": "JAMA Oncol",
      "key": "9956_CR11",
      "unstructured": "Desmond A, Kurian AW, Gabree M, Mills MA, Anderson MJ, Kobayashi Y, Horick N, Yang S, Shannon KM, Tung N, Ford JM, Lincoln SE, Ellisen LW (2015) Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment. JAMA Oncol 1(7):943–951",
      "volume": "1",
      "year": "2015"
    },
    {
      "key": "9956_CR12",
      "unstructured": "Daly MB, Pilarski R, Axilbund JE, et al (2016). Genetic/familial high-risk assessment: breast and ovarian, version I. 2016. \n                        http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf\n                        \n                    . Accessed 29 Feb 2016"
    },
    {
      "DOI": "10.1016/j.molonc.2008.09.007",
      "author": "J Bartkova",
      "doi-asserted-by": "crossref",
      "first-page": "296",
      "journal-title": "Mol Oncol",
      "key": "9956_CR13",
      "unstructured": "Bartkova J, Tommiska J, Oplustilova L et al (2008) Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene. Mol Oncol 2:296–316",
      "volume": "2",
      "year": "2008"
    },
    {
      "DOI": "10.1186/bcr3669",
      "author": "F Damiola",
      "doi-asserted-by": "crossref",
      "first-page": "R58",
      "journal-title": "Breast Cancer Res",
      "key": "9956_CR14",
      "unstructured": "Damiola F, Pertesi M, Oliver J et al (2014) Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study. Breast Cancer Res 16:R58",
      "volume": "16",
      "year": "2014"
    },
    {
      "DOI": "10.1056/NEJMsr1501341",
      "author": "DF Easton",
      "doi-asserted-by": "crossref",
      "first-page": "2243",
      "issue": "23",
      "journal-title": "N Engl J Med",
      "key": "9956_CR15",
      "unstructured": "Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL et al (2015) Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372(23):2243–2257",
      "volume": "372",
      "year": "2015"
    },
    {
      "DOI": "10.1056/NEJMe1506276",
      "author": "EG Phimister",
      "doi-asserted-by": "crossref",
      "first-page": "2227",
      "journal-title": "N Engl J Med",
      "key": "9956_CR16",
      "unstructured": "Phimister EG (2015) Curating the way to better determinants of genetic risk. N Engl J Med 372:2227–2228",
      "volume": "372",
      "year": "2015"
    },
    {
      "DOI": "10.1038/1722",
      "author": "T Woodage",
      "doi-asserted-by": "crossref",
      "first-page": "62",
      "issue": "1",
      "journal-title": "Nat Genet",
      "key": "9956_CR17",
      "unstructured": "Woodage T, King SM, Wacholder S, Hartge P, Struewing JP, McAdams M et al (1998) The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet 20(1):62–65",
      "volume": "20",
      "year": "1998"
    },
    {
      "DOI": "10.1016/j.ejca.2010.04.020",
      "author": "HL Wong",
      "doi-asserted-by": "crossref",
      "first-page": "2457",
      "issue": "13",
      "journal-title": "Eur J Cancer",
      "key": "9956_CR18",
      "unstructured": "Wong HL, Peters U, Hayes RB, Huang WY, Schatzkin A, Bresalier RS et al (2010) Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk. Eur J Cancer 46(13):2457–2466",
      "volume": "46",
      "year": "2010"
    },
    {
      "DOI": "10.1073/pnas.0407187101",
      "author": "NS Fearnhead",
      "doi-asserted-by": "crossref",
      "first-page": "15992",
      "issue": "45",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "9956_CR19",
      "unstructured": "Fearnhead NS, Wilding JL, Winney B, Tonks S, Bartlett S, Bicknell DC et al (2004) Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc Natl Acad Sci USA 101(45):15992–15997",
      "volume": "101",
      "year": "2004"
    },
    {
      "author": "HT Lynch",
      "first-page": "801",
      "issue": "11",
      "journal-title": "J Med Genet",
      "key": "9956_CR20",
      "unstructured": "Lynch HT, de la Chapelle A (1999) Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 36(11):801–818",
      "volume": "36",
      "year": "1999"
    },
    {
      "DOI": "10.1086/302262",
      "author": "R Gryfe",
      "doi-asserted-by": "crossref",
      "first-page": "378",
      "issue": "2",
      "journal-title": "Am J Hum Genet",
      "key": "9956_CR21",
      "unstructured": "Gryfe R, Di Nicola N, Lal G, Gallinger S, Redston M (1999) Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. Am J Hum Genet 64(2):378–384",
      "volume": "64",
      "year": "1999"
    },
    {
      "author": "NS Kapoor",
      "first-page": "3282",
      "issue": "10",
      "journal-title": "Ann SurgOncol",
      "key": "9956_CR22",
      "unstructured": "Kapoor NS, Curcio LD, Blakemore CA, Bremner AK, McFarland RE, West JG, Banks KC (2015) Multigene panel testing detects equal rates of pathogenic BRCA1/2 mutations and has a higher diagnostic yield compared to limited BRCA1/2 Analysis alone in patients at risk for hereditary breast cancer. Ann SurgOncol 22(10):3282–3288",
      "volume": "22",
      "year": "2015"
    },
    {
      "DOI": "10.1002/mgg3.157",
      "author": "Y Hirotsu",
      "doi-asserted-by": "crossref",
      "first-page": "459",
      "issue": "5",
      "journal-title": "Mol Genet Genomic Med",
      "key": "9956_CR23",
      "unstructured": "Hirotsu Y, Nakagomi H, Sakamoto I, Amemiya K, Oyama T, Mochizuki H, Omata M (2015) Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer. Mol Genet Genomic Med 3(5):459–466",
      "volume": "3",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ejhg.2014.16",
      "author": "L Castéra",
      "doi-asserted-by": "crossref",
      "first-page": "1305",
      "issue": "11",
      "journal-title": "Eur J Hum Genet",
      "key": "9956_CR24",
      "unstructured": "Castéra L, Krieger S, Rousselin A et al (2014) Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes. Eur J Hum Genet 22(11):1305–1313",
      "volume": "22",
      "year": "2014"
    },
    {
      "DOI": "10.1073/pnas.1115052108",
      "author": "T Walsh",
      "doi-asserted-by": "crossref",
      "first-page": "18032",
      "issue": "44",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "9956_CR25",
      "unstructured": "Walsh T, Casadei S, Lee MK et al (2011) Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci USA 108(44):18032–18037",
      "volume": "108",
      "year": "2011"
    },
    {
      "DOI": "10.1038/gim.2014.176",
      "author": "KN Maxwell",
      "doi-asserted-by": "crossref",
      "first-page": "630",
      "issue": "8",
      "journal-title": "Genet Med",
      "key": "9956_CR26",
      "unstructured": "Maxwell KN, Wubbenhorst B, D’Andrea K et al (2015) Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer. Genet Med 17(8):630–638",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1002/humu.20880",
      "author": "SE Plon",
      "doi-asserted-by": "crossref",
      "first-page": "1282",
      "issue": "11",
      "journal-title": "Hum Mutat",
      "key": "9956_CR27",
      "unstructured": "Plon SE, Eccles DM, Easton D et al (2008) IARC Unclassified Genetic Variants Working Group. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 29(11):1282–1291",
      "volume": "29",
      "year": "2008"
    },
    {
      "DOI": "10.1038/ejhg.2012.217",
      "author": "R Cook-Deegan",
      "doi-asserted-by": "crossref",
      "first-page": "585",
      "issue": "6",
      "journal-title": "Eur J Hum Genet",
      "key": "9956_CR28",
      "unstructured": "Cook-Deegan R, Conley JM, Evans JP, Vorhaus D (2013) The next controversy in genetic testing: clinical data as trade secrets? Eur J Hum Genet 21(6):585–588",
      "volume": "21",
      "year": "2013"
    },
    {
      "DOI": "10.1200/JCO.2012.42.7336",
      "author": "M Weischer",
      "doi-asserted-by": "crossref",
      "first-page": "4308",
      "issue": "35",
      "journal-title": "J Clin Oncol",
      "key": "9956_CR29",
      "unstructured": "Weischer M, Nordestgaard BG, Pharoah P et al (2012) CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. J Clin Oncol 30(35):4308–4316",
      "volume": "30",
      "year": "2012"
    },
    {
      "DOI": "10.1200/JCO.2007.12.5922",
      "author": "M Weischer",
      "doi-asserted-by": "crossref",
      "first-page": "542",
      "issue": "4",
      "journal-title": "J Clin Oncol",
      "key": "9956_CR30",
      "unstructured": "Weischer M, Bojesen SE, Ellervik C, Tybjaerg-Hansen A, Nordestgaard BG (2008) CHEK2* 1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls. J Clin Oncol 26(4):542–548",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1038/ng1837",
      "author": "A Renwick",
      "doi-asserted-by": "crossref",
      "first-page": "873",
      "issue": "8",
      "journal-title": "Nat Genet",
      "key": "9956_CR31",
      "unstructured": "Renwick A, Thompson D, Seal S et al (2006) Breast Cancer Susceptibility Collaboration (UK), Easton DF, Stratton MR, Rahman N. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 38(8):873–875",
      "volume": "38",
      "year": "2006"
    },
    {
      "DOI": "10.1111/j.1524-4741.2012.01274.x",
      "author": "UO Njiaju",
      "doi-asserted-by": "crossref",
      "first-page": "436",
      "issue": "5",
      "journal-title": "Breast J",
      "key": "9956_CR32",
      "unstructured": "Njiaju UO, Olopade OI (2012) Genetic determinants of breast cancer risk: a review of current literature and issues pertaining to clinical application. Breast J 18(5):436–442",
      "volume": "18",
      "year": "2012"
    },
    {
      "DOI": "10.1136/jmg.2007.051268",
      "author": "S Masciari",
      "doi-asserted-by": "crossref",
      "first-page": "726",
      "issue": "11",
      "journal-title": "J Med Genet",
      "key": "9956_CR33",
      "unstructured": "Masciari S, Larsson N, Senz J et al (2007) Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet 44(11):726–731",
      "volume": "44",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.ajhg.2012.05.021",
      "author": "JJ Johnston",
      "doi-asserted-by": "crossref",
      "first-page": "97",
      "issue": "1",
      "journal-title": "Am J Hum Genet",
      "key": "9956_CR34",
      "unstructured": "Johnston JJ, Rubinstein WS, Facio FM et al (2012) Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. Am J Hum Genet 91(1):97–108",
      "volume": "91",
      "year": "2012"
    },
    {
      "DOI": "10.1136/jmedgenet-2015-103094",
      "author": "RS Post van der",
      "doi-asserted-by": "crossref",
      "first-page": "361",
      "issue": "6",
      "journal-title": "J Med Genet",
      "key": "9956_CR35",
      "unstructured": "van der Post RS, Vogelaar IP, Carneiro F et al (2015) Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet 52(6):361–374",
      "volume": "52",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nature10760",
      "author": "CJ Lord",
      "doi-asserted-by": "crossref",
      "first-page": "287",
      "issue": "7381",
      "journal-title": "Nature",
      "key": "9956_CR36",
      "unstructured": "Lord CJ, Ashworth A (2012) The DNA damage response and cancer therapy. Nature 481(7381):287–294",
      "volume": "481",
      "year": "2012"
    },
    {
      "key": "9956_CR37",
      "unstructured": "Telli M. Talazoparib beyond BRCA (TBB) trial. In: ClinicalTrials.gov: National Library of Medicine (US), Bethesda. \n                        https://clinicaltrials.gov/ct2/show/NCT02401347\n                        \n                    . Accessed 21 Mar 2016"
    },
    {
      "DOI": "10.1200/JCO.2012.46.9403",
      "author": "SM Domchek",
      "doi-asserted-by": "crossref",
      "first-page": "1267",
      "issue": "10",
      "journal-title": "J Clin Oncol",
      "key": "9956_CR38",
      "unstructured": "Domchek SM, Bradbury A, Garber JE, Offit K, Robson ME (2013) Multiplex genetic testing for cancer susceptibility: out on the high wire without a net? J Clin Oncol 31(10):1267–1270",
      "volume": "31",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nrg3463",
      "author": "HL Rehm",
      "doi-asserted-by": "crossref",
      "first-page": "295",
      "issue": "4",
      "journal-title": "Nat Rev Genet",
      "key": "9956_CR39",
      "unstructured": "Rehm HL (2013) Disease-targeted sequencing: a cornerstone in the clinic. Nat Rev Genet 14(4):295–300",
      "volume": "14",
      "year": "2013"
    }
  ],
  "reference-count": 39,
  "references-count": 39,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-016-9956-7"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Outcomes of retesting BRCA negative patients using multigene panels"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "16"
}